Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

October 16, 2025 | Participant engagement, Patient Voice, clinical trials 

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Report fan imager

CAMBRIDGE, UK – October 16, 2025 – Healthcare communications agency Cuttsy+Cuttsy, in collaboration with the International Society for Patient Engagement Professionals (ISPEP), today announced the release of The participation equation, a comprehensive report exploring what drives participant engagement in modern clinical trials. The research offers a fresh, 360-degree perspective by combining quantitative data from 700 clinical trial participants, alongside in-depth qualitative interviews and industry leader insights.

The report reveals a significant shift in how people discover clinical trials, with 45% of survey respondents learning about opportunities through social media. This highlights a growing reliance on patients to find trials independently, rather than through healthcare professionals. The findings suggest that while patients are taking charge of their health decisions, more can be done to create proactive and supportive pathways to trial participation.

The participation equation also establishes a clear link between a participant’s trial experience and their likelihood of completing that trial. The data shows that trial completion rates increase in line with positive experience scores. A key factor in this is the level of support felt from the trial healthcare team; participants who said they ‘definitely’ felt supported had a 92% trial completion rate. The report further emphasises that ongoing and empathetic human connection in combination with high-quality and supportive resources are vital for retention.

“This report brings forward the experiences of patients who have recently participated in modern trials reflective of today’s research landscape and the growing complexity in the trials landscape” says Alexandra Charge, CEO & Co-Founder of ISPEP. “Their insights go beyond ‘what happened’ to reveal ‘why it mattered’, highlighting where trial processes supported them and where gaps remain.”

The research provides actionable insights for the industry, by providing credible evidence sources that are aligned with participant preferences to support and improve recruitment, retention, and data quality. By understanding how participants weigh burdens against benefits and what support they truly need, sponsors can move from patient-informed trials to truly patient-ready ones. The report is a call to action for the clinical research community to operationalise patient preference into trial design and delivery.

Download The participation equation to learn more about the evolving landscape of patient engagement and discover how to better align trial processes with patient needs.

The full report is available to download here.

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.